VIZO Specs
Wearable Eyewear with Personalized Stimuli for ADHD Management
Company Overview
Snapshot
Founded in May 2017 by Yoav Kahane, VIZO Specs operates with 11–50 employees. The company has secured funding across one round. In August 2020, VIZO Specs received seed funding from Gai Anbar, marking a key milestone in its development of wearable technology for ADHD management.
Business overview
VIZO Specs develops SPARKLES, a line of personalized wearable eyewear designed to assist in managing ADHD through science-driven technology. These glasses incorporate embedded personalized stimuli that deliver real-time, adaptive visual feedback to enhance attention and focus. The company's products are approved with a CE mark and Israeli Ministry of Health certification, providing an innovative solution for individuals with attention difficulties. VIZO Specs operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Assistive Devices, and targets consumers with its B2C business model.
Strategic signal
VIZO Specs' SPARKLES eyewear has received a CE mark and Israeli Ministry of Health certification, indicating regulatory approval and market readiness for its innovative ADHD management solution. This validation is a strong signal to investors and the market regarding the product's safety, efficacy, and potential for broader adoption, positioning VIZO Specs for growth in the health tech and assistive devices sector.
Company Intelligence Q&A
- What is VIZO Specs' core product?
- VIZO Specs develops SPARKLES, personalized wearable eyewear designed to help manage ADHD by providing real-time, adaptive visual feedback to improve attention and focus.
- When was VIZO Specs founded and by whom?
- VIZO Specs was founded in May 2017 by Yoav Kahane.
- Has VIZO Specs received any regulatory approvals for its products?
- Yes, VIZO Specs' SPARKLES glasses have received a CE mark and Israeli Ministry of Health certification.
- What is the primary market focus for VIZO Specs?
- VIZO Specs primarily targets consumers with its wearable assistive devices, operating within the Health Tech & Life Sciences sector.